Inventor · disambiguated record
Sharon Avkin-Nachum
Also filed as: AVKIN-NACHUM SHARON
21 granted patents·8 pending applications·99 citations·filing 2010–2018
93Inventor score
Files withQUARK PHARMACEUTICALS INC12AVKIN-NACHUM SHARON6QBI ENTPR LTD4NITTO DENKO CORP3FEINSTEIN ELENA2
Top patents by PatentIndex Score
29 records- 0195US9932578B2Double-stranded oligonucleotide molecules to P53 and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2013·Granted Apr 3, 2018·31 cites·9 claims
- 0293US9206424B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2014·Granted Dec 8, 2015·21 cites·33 claims
- 0390US8710209B2Modulation of HSP47 expressionJIN XIAOMEI·Filed 2010·Granted Apr 29, 2014·22 cites·37 claims
- 0486US10093923B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2015·Granted Oct 9, 2018·5 cites·35 claims
- 0582US8796239B2Sirna compounds comprising terminal substitutionsAVKIN-NACHUM SHARON·Filed 2010·Granted Aug 5, 2014·6 cites·18 claims
- 0676US8859751B2Oligonucleotide compounds comprising non-nucleotide overhangsAVKIN-NACHUM SHARON·Filed 2011·Granted Oct 14, 2014·3 cites·22 claims
- 0775US10421962B2Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·1 cites·6 claims
- 0873US9611474B2Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2013·Granted Apr 4, 2017·1 cites·20 claims
- 0973US9249414B2Oligonucleotide compounds comprising non-nucleotide overhangsQUARK PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·1 cites·20 claims
- 1072US9205100B2Compositions and methods for treating lung disease and injuryGELMAN ANDREW E·Filed 2012·Granted Dec 8, 2015·3 cites·6 claims
- 1171US9822362B2Compositions and methods for treating lung disease and injuryQUARK PHARMACEUTICALS INC·Filed 2015·Granted Nov 21, 2017·1 cites·19 claims
- 1271US9701960B2siRNA compounds comprising terminal substitutionsQUARK PHARMACEUTICALS INC·Filed 2014·Granted Jul 11, 2017·1 cites·18 claims
- 1370US9045755B2Double stranded RNA compounds to RhoA and use thereofAVKIN-NACHUM SHARON·Filed 2011·Granted Jun 2, 2015·1 cites·9 claims
- 1468US9487778B2Oligonucleotide modulators of the toll-like receptor pathwayFEINSTEIN ELENA·Filed 2012·Granted Nov 8, 2016·1 cites·16 claims
- 1561US10059942B2Therapeutic oligonucleotides comprising pyrazolotriazine nucleotide analoguesQBI ENTPR LTD·Filed 2013·Granted Aug 28, 2018·1 cites·12 claims
- 1655US10494631B2siRNA compounds comprising terminal substitutionsQUARK PHARMACEUTICALS INC·Filed 2017·Granted Dec 3, 2019·0 cites·2 claims
- 1753US9796979B2Oligonucleotide modulators of the toll-like receptor pathwayQUARK PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·0 cites·10 claims
- 1850US2016333354A1Double stranded rna compounds to rhoa and use thereofAVKIN-NACHUM SHARON·Filed 2016·Application pending·0 cites
- 1948US9611473B2Double-stranded nucleic acid compoundsQUARK PHARMACEUTICALS INC·Filed 2013·Granted Apr 4, 2017·0 cites·19 claims
- 2048US2016102313A1Double stranded rna compounds to rhoa and use thereofAVKIN-NACHUM SHARON·Filed 2015·Application pending·0 cites
- 2147US10781449B2Double-stranded oligonucleotide molecules targeting p53 and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2018·Granted Sep 22, 2020·0 cites·11 claims
- 2247US2013030034A9Modulation of timp1 and timp2 expressionQUARK PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 2346US2016208247A1Methods of use of sphingolipid polyalkylamine oligonucleotide compoundsQBI ENTPR LTD·Filed 2014·Application pending·0 cites
- 2444US2016281083A1Modulation of timp1 and timp2 expressionNITTO DENKO CORP·Filed 2015·Application pending·0 cites
- 2543US9889200B2Sphingolipid-polyalkylamine-oligonucleotide compoundsQBI ENTPR LTD·Filed 2014·Granted Feb 13, 2018·0 cites·15 claims
- 2642US2013324591A1Double stranded oligonucleotide compounds comprising positional modificationsAVKIN-NACHUM SHARON·Filed 2011·Application pending·0 cites
- 2742US2015018404A1Double-stranded oligonucleotide compounds for treating hearing and balance disordersFEINSTEIN ELENA·Filed 2012·Application pending·0 cites
- 2841US10144928B2Double stranded oligonucleotide compounds comprising positional modificationsQUARK PHARMACEUTICALS INC·Filed 2016·Granted Dec 4, 2018·0 cites·23 claims
- 2931US2016152979A1Novel compoundsQBI ENTPR LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sharon Avkin-Nachum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →